Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Microtransplantation for Advanced and Relapsed Solid Tumors
NCT07356856Phase 1Not yet recruiting
- Sponsor
- 307 Hospital of the People's Liberation Army
- Start
- Jan 2026
- Primary completion
- Jan 2028
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of HLA-mismatched microtransplantation in solid tumor, sponsored by 307 Hospital of the People's Liberation Army. Primary endpoints: Treatment-Emergent Adverse Events at 1 month and Time of hematopoietic recovery at 1 month. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
HLA-mismatched microtransplantation
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT07356856.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07356856.